Rockwell Medical to Buy Vantive Hemodialysis Business for $125 Million

By Colin Kellaher

Rockwell Medical has agreed to buy the majority of the assets and associated operations of privately held Vantive's hemodialysis business for a base purchase price of $125 million.

Rockwell on Tuesday said the deal includes Vantive's hemodialysis concentrates, HD machines including AK-98, water-treatment systems and a 1-million-square-foot manufacturing campus in Medolla, Italy.

The Wixom, Mich., healthcare company said it plans to finance the purchase through two $50 million term loans from Vantive, plus a $25 million convertible note issued to Vantive, adding that Vantive may receive up to $45 million of additional consideration based on certain financial milestones.

The deal is slated to close in mid-2027.

Rockwell, which previously forecast 2026 sales of $70 million to $75 million, said it estimates the combined business could generate annual revenue between $400 million and $450 million.

The company said it is withdrawing its 2026 financial guidance due to projected expenses related to the transaction.

Private-equity firm Carlyle Group acquired Vantive, formerly Baxter International's kidney-care segment, from Baxter in a $3.8 billion deal last year.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

November 03, 2026 07:37 ET (12:37 GMT)